L. Browne

L. Browne

Presidente en Rythera Therapeutics, Inc. .

63 años
Health Technology
Consumer Services
Process Industries

Perfil

L.
Daniel Browne
was the founder of Revance Therapeutics, Inc. (founded in 1999) where he held the title of President, Chief Executive Officer & Director from 2014 to 2019.
Currently, he is the Chairman at Rythera Therapeutics, Inc. (since 2020), a Director at Galderma Holding SA, and an Independent Director at Galderma Group AG (since 2022).
In the past, he served as the President & Chief Executive Officer of Neomend, Inc. (2001-2003) and Prograft Medical, Inc. (1997-2000).
He also served as a Director at Avava, Inc. (2020-2022) and held a Business Leader position at W.
L.
Gore & Associates, Inc. Mr. Browne completed his undergraduate degree at the University of Hawai'i at Hilo and holds an MBA from Pepperdine Graziadio Business School.

Cargos activos de L. Browne

EmpresasCargoInicio
Director/Miembro de la Junta -
Rythera Therapeutics, Inc. Presidente 01/09/2020
Todos los cargos activos de L. Browne

Antiguos cargos conocidos de L. Browne.

EmpresasCargoFin
Director/Miembro de la Junta 01/05/2022
REVANCE THERAPEUTICS, INC. Fundador 14/10/2019
Director Ejecutivo -
Prograft Medical, Inc. Director Ejecutivo -
Corporate Officer/Principal -
Ver el detalle de la experiencia de L. Browne.

Formación de L. Browne.

University of Hawai'i at Hilo Undergraduate Degree
Pepperdine Graziadio Business School Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de L. Browne.

Relaciones

61

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
REVANCE THERAPEUTICS, INC.

Health Technology

Empresas privadas6

Health Technology

Process Industries

Prograft Medical, Inc.

Health Technology

Rythera Therapeutics, Inc.

Technology Services

Ver las conexiones de la empresa